| Revenue | 162.35M |
| Research and development | 3.92M |
| General and administrative | |
| In-process research and development costs | |
| Goodwill impairment | |
| Total operating expenses | |
| Loss from operations | 118.23M |
| Other income (expense) | -27K |
| Interest expense on note payable to related party | -729K |
| Interest expense on senior convertible notes | -4.17M |
| Interest income | 28K |
| Loss before provision for income taxes | |
| Income taxes | 0 |
| Net loss | 126.52M |
| Deemed dividend related to beneficial conversion feature of convertible preferred stock | |
| Accretion on redeemable preferred stock | |
| Net loss applicable to common stockholders | |
| Net loss per share applicable to common stockholders - basic and diluted | |
| Shares used to compute basic and diluted net loss per share applicable to common stockholders | |